학술논문
Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study
Document Type
Article
Author
Laubach, J.P.; Richardson, P.G.; Schjesvold, F.; Mariz, M.; Dimopoulos, M.A.; Lech-Maranda, E.; Spicka, I.; Hungria, V.T.M.; Shelekhova, T.; Abdo, A.; Jacobasch, L.; Polprasert, C.; Hájek, R.; Illés, Á.; Wróbel, T.; Sureda, A.; Beksac, M.; Gonçalves, I.Z.; Bladé, J.; Rajkumar, S.V.; Chari, A.; Lonial, S.; Spencer, A.; Maison-Blanche, P.; Moreau, P.; San-Miguel, J.F.
Source
In: The Lancet Oncology . (The Lancet Oncology, January 2021, 22(1):142-154)
Subject
Language
English
ISSN
14745488
14702045
14702045